Own Products & Pipeline

KD BIOPHARMA

In addition to the family of Omega-3 fatty acids the KD Pharma Group is continuously developing innovative drugs for unmet medical needs.

Our actual pipeline:

• ALFA Gastro-resistant Capsules for the treatment of Familial Adenomatous Polyposis (FAP), phase III
• ALFA Gastro-resistant Capsules for the treatment of Ulcerative Colitis (UC)

Are you interested in becoming our Licensing Partner? Please contact us at: pharma@kdpharmagroup.com